Display options
Share it on

Histochem Cell Biol. 2016 Nov;146(5):557-567. doi: 10.1007/s00418-016-1460-5. Epub 2016 Jul 04.

Biogenesis of a new type of extracellular vesicles in gastrointestinal stromal tumors: ultrastructural profiles of spheresomes.

Histochemistry and cell biology

Concepción Junquera, Tomás Castiella, Guillermo Muñoz, Rodrigo Fernández-Pacheco, M José Luesma, Marta Monzón

Affiliations

  1. Faculty of Medicine, Institute for Health Research Aragón (IIS), C/Domingo Miral s/n, 50009, Saragossa, Spain. [email protected].
  2. University Hospital Lozano Blesa, University of Zaragoza, Saragossa, Spain.
  3. LMA (Advanced Microscopy Laboratory), Institute of Nanoscience of Aragón, Saragossa, Spain.
  4. Faculty of Medicine, Institute for Health Research Aragón (IIS), C/Domingo Miral s/n, 50009, Saragossa, Spain.

PMID: 27373548 DOI: 10.1007/s00418-016-1460-5

Abstract

Extracellular vesicles (EVs) have emerged as an intercellular communication mediator in cancer. They seem to be involved in tumor processes by means of transformation of surrounding cells previous to metastasis by transferring miRNAs and oncogenic proteins. It is known that EVs, depending on their source, can be exosomes or ectosomes. Although the first type constitutes a specific population formed from the endosomal system, via multivesicular bodies, the ectosome biogenesis is not yet well known. In this study, we report a new type of EVs which has been termed spheresomes. While exosomes come from multivesicular bodies and ectosomes from direct budding of plasma membrane, spheresomes present a new mechanism of shedding from a spherical membrane structure which we have named multivesicular spheres. These EVs are first described in gastrointestinal stromal tumor cells in the present study. But moreover, these new membrane spherical structures appear not only next to tumoral cells but also different distances from them. Since some other authors have evidenced oncogenic KIT-containing EVs, it is also suggested here that surrounding cells uptake of these first described EVs, GIST-derived spheresomes, could induce tumor invasiveness. That is why the prevention of signaling processes developed by these new EVs may represent an alternative approach for GIST treatment.

Keywords: EVs and cancer; Exosomes; Extracellular vesicles; GIST; Oncosomes

References

  1. Anticancer Res. 1998 Sep-Oct;18(5A):3433-7 - PubMed
  2. J Cell Biol. 2006 Mar 13;172(6):923-35 - PubMed
  3. BMC Cancer. 2009 Jul 20;9:244 - PubMed
  4. J Extracell Vesicles. 2013 Mar 19;2:null - PubMed
  5. Trends Mol Med. 2014 Jul;20(7):385-93 - PubMed
  6. Blood. 2008 Sep 15;112(6):2327-35 - PubMed
  7. J Cell Biol. 1985 Sep;101(3):942-8 - PubMed
  8. Genes Dev. 2012 Jun 15;26(12):1287-99 - PubMed
  9. J Cell Biol. 2013 Feb 18;200(4):373-83 - PubMed
  10. J Neurooncol. 2013 May;113(1):1-11 - PubMed
  11. J Cell Mol Med. 2011 Jan;15(1):26-30 - PubMed
  12. Nat Med. 2012 Jun;18(6):883-91 - PubMed
  13. Inflamm Res. 2009 Jan;58(1):1-8 - PubMed
  14. Curr Biol. 2009 Dec 1;19(22):1875-85 - PubMed
  15. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):711-6 - PubMed
  16. J Cell Mol Med. 2015 Aug;19(8):1783-94 - PubMed
  17. Nat Med. 2012 Jun 06;18(6):853-4 - PubMed
  18. Cancer Microenviron. 2012 Dec;5(3):323-32 - PubMed
  19. Nat Cell Biol. 2010 Jan;12 (1):19-30; sup pp 1-13 - PubMed
  20. Platelets. 2004 Mar;15(2):109-15 - PubMed
  21. Nature. 2005 Dec 8;438(7069):820-7 - PubMed
  22. Curr Opin Oncol. 2013 Jan;25(1):66-75 - PubMed
  23. Clin Exp Metastasis. 1999 Mar;17(2):131-40 - PubMed
  24. Leukemia. 2006 Sep;20(9):1487-95 - PubMed
  25. Am J Pathol. 1998 May;152(5):1259-69 - PubMed
  26. Nat Rev Immunol. 2002 Aug;2(8):569-79 - PubMed
  27. Science. 1998 Jan 23;279(5350):577-80 - PubMed
  28. Nat Commun. 2015 Apr 01;6:6716 - PubMed
  29. Cancer Res. 2011 Aug 1;71(15):5346-56 - PubMed
  30. J Cell Mol Med. 2015 Apr;19(4):714-22 - PubMed
  31. Cancer Res. 2011 Jun 1;71(11):3792-801 - PubMed
  32. Front Genet. 2013 Jul 30;4:142 - PubMed
  33. Clin Sci (Lond). 2013 Apr;124(7):423-41 - PubMed
  34. Kidney Int. 2010 Nov;78(9):838-48 - PubMed
  35. J Cell Mol Med. 2013 Jul;17 (7):844-53 - PubMed
  36. Mass Spectrom Rev. 2015 Jul-Aug;34(4):474-90 - PubMed
  37. Cancer Res. 2014 Feb 1;74(3):738-750 - PubMed
  38. Traffic. 2011 Dec;12(12):1659-68 - PubMed
  39. Int J Nanomedicine. 2010 Nov 10;5:889-900 - PubMed
  40. Cancer Res. 1998 Oct 1;58(19):4468-74 - PubMed
  41. Cancer Res. 2004 Oct 1;64(19):7045-9 - PubMed
  42. Toxicol Pathol. 2007 Jun;35(4):495-516 - PubMed
  43. Curr Opin Cell Biol. 2004 Aug;16(4):415-21 - PubMed
  44. Proteomics. 2013 May;13(10-11):1554-71 - PubMed
  45. Cancer Biomark. 2013;13(5):351-7 - PubMed
  46. J Cell Mol Med. 2014 Oct;18(10):1938-43 - PubMed
  47. Trends Cell Biol. 2009 Feb;19(2):43-51 - PubMed
  48. J Cell Mol Med. 2011 Dec;15(12):2594-600 - PubMed
  49. J Extracell Vesicles. 2012 Sep 11;1:null - PubMed
  50. Cell Mol Life Sci. 2011 Aug;68(16):2667-88 - PubMed
  51. Blood. 1989 Oct;74(5):1844-51 - PubMed

MeSH terms

Publication Types